Gilead loses another challenge to U.S. patents for HIV prevention - STAT

Gilead loses another challenge to U.S. patents for HIV prevention - STAT

STAT Plus: Gilead loses another challenge to a pair of U.S. patents for an HIV prevention pill

By ED SILVERMAN

JEFF CHIU/AP

“This validates what we’ve been saying all along — that the CDC patents are valid and enforceable,” said James Krellenstein of the PrEP4All Collaboration.

READ MORE